Preoperative assessment and management of pediatric heart transplantation

Mudge, 1993, 24th Bethesda Conference. Heart transplantation. Task Force 3: recipient guidelines/prioritization, J Am Coll Cardiol, 22, 21, 10.1016/0735-1097(93)90812-F O’Connell, 1992, Cardiac transplantation: recipient selection, donor procurement, and medical follow-up, Circulation, 86, 1061, 10.1161/01.CIR.86.3.1061 Costanzo, 1995, Selection and treatment of candidates for heart transplantation, Circulation, 92, 3593, 10.1161/01.CIR.92.12.3593 Fricker, 1999, Heart transplantation in children. Indications, Pediatr Transplant, 3, 333, 10.1034/j.1399-3046.1999.00045.x Webber, 1994, Orthotopic heart transplantation in children with congenital heart disease, Ann Thorac Surg, 58, 1664, 10.1016/0003-4975(94)91655-1 Mayer, 1990, Orthotopic heart transplantation for complex congenital heart disease, J Thorac Cardiovasc Surg, 99, 484, 10.1016/S0022-5223(19)36979-X Doty, 1990, Cardiac transplantation in situs inversus, J Thorac Cardiovasc Surg, 99, 493, 10.1016/S0022-5223(19)36980-6 Cooper, 1991, Pediatric heart transplantation after operations involving the pulmonary arteries, J Thorac Cardiovasc Surg, 102, 386, 10.1016/S0022-5223(19)36521-3 Schwartz, 1996, Clinical approach to genetic cardiomyopathy in children, Circulation, 94, 2021, 10.1161/01.CIR.94.8.2021 Dunnigan, 1987, Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure, J Am Coll Cardiol, 10, 608, 10.1016/S0735-1097(87)80204-8 Munoz, 1992, Long-term results in diabetic patients undergoing heart transplantation, J Heart Lung Transplant, 11, 943 Erice, 1991, Outcome of solid organ transplantation in patients with HIV virus, Rev Infect Dis, 13, 537, 10.1093/clinids/13.4.537 Wedemeyer, 1998, Long-term outcome of chronic hepatitis B in heart transplant recipients, Transplantation, 66, 1347, 10.1097/00007890-199811270-00015 Lake, 1997, Outcome of hepatitis C+ heart transplant recipients, Transplant Proc, 29, 581, 10.1016/S0041-1345(96)00312-0 Lake, 1999, The Cardiac Transplant Research Database (CTRD). Outcomes with hepatitis C following cardiac transplantation — a multi-institutional study (abstract), J Heart Lung Transplant, 18, 81, 10.1016/S1053-2498(99)80198-3 Itescu, 1998, Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation, Circulation, 98, 786, 10.1161/01.CIR.98.8.786 Shaddy, 1996, Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery, Circulation, 94, 1063, 10.1161/01.CIR.94.5.1063 Stringham, 1999, Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization, J Heart Lung Transplant, 18, 160, 10.1016/S1053-2498(98)00006-0 Dowling, 1998, Use of intravenous immunoglobulin in sensitized LVAD recipients, Transplant, 30, 1110, 10.1016/S0041-1345(98)00172-9 Robinson, 1997, Plasmapharesis followed by intravenous immunoglobulin in presensitized patients awaiting heart transplantation, Ther Apheresis, 1, 147, 10.1111/j.1744-9987.1997.tb00030.x Ibrahim, 1999, Successful cardiac transplantation of pre-sensitized children without a prospective crossmatch — preliminary results (abstract), J Heart Lung Transplant, 18, 83, 10.1016/S1053-2498(99)80210-1 Goldstein, 1995, Orthotopic heart transplantation in patients with treated malignancies, Am J Cardiol, 75, 968, 10.1016/S0002-9149(99)80704-8 Paris, 1994, Study of the relative incidences of psychosocial factors before and after heart transplantation and the influence of post-transplantation psychosocial factors on heart transplantation outcomes, J Heart Lung Transplant, 13, 424 Shapiro, 1995, Psychosocial evaluation and prediction of compliance problems and morbidity after heart transplantation, Transplantation, 60, 1462, 10.1097/00007890-199560120-00016 Van Meter CH, Heiney DA. Modifications to and implementation of UNOS policy 3.7 (Allocations of thoracic organs). UNOS policy communication. United Network for Organ Sharing, PO Box 13770, Richmond, VA, USA, December 1998. Stevenson, 1991, Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics, J Heart Lung Transplant, 10, 468 VanVeldhuisen, 1998, High- versus low-dose ACE inhibition in chronic heart failure: a double blind, placebo-controlled study of imidapril, J Am Coll Cardiol, 32, 1811, 10.1016/S0735-1097(98)00464-1 Armstrong, 1994, Medical advances in the treatment of congestive heart failure, Circulation, 88, 2941, 10.1161/01.CIR.88.6.2941 Hamroff, 1999, Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure, Circulation, 99, 990, 10.1161/01.CIR.99.8.990 Lechat, 1998, Clinical effects of B-adrenergic blockade in chronic heart failure. A meta-analysis of double-blind placebo-controlled, randomized trials, Circulation, 98, 1184, 10.1161/01.CIR.98.12.1184 Shakar, 1998, Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure, J Am Coll Cardiol, 31, 1336, 10.1016/S0735-1097(98)00077-1 Shaddy, 1999, Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience, J Heart Lung Transplant, 18, 269, 10.1016/S1053-2498(98)00030-8 Batista, 1996, Partial left ventriculectomy to improve left ventricular function in end-stage heart diseases, J Card Surg, 11, 96, 10.1111/j.1540-8191.1996.tb00019.x Moreira, 1998, Partial left ventriculectomy with mitral valve preservation in the treatment of patients with dilated cardiomyopathy, J Thorac Cardiovasc Surg, 1115, 800, 10.1016/S0022-5223(98)70358-7 Stolf, 1998, Determinants of midterm outcome of partial left ventriculectomy in dilated cardiomyopathy, Ann Thorac Surg, 66, 1585, 10.1016/S0003-4975(98)00959-X Berger S, Tweddel JS, Frommelt PC, Weinhaus. Partial left ventriculectomy for dilated cardiomyopathy in a newborn. J Thorac Cardiovasc Surg 1999;117:1017–1018. Yoshii, 1999, Partial left ventriculectomy in an infant with dilated cardiomyopathy, J Thorac Cardiovasc Surg, 117, 622, 10.1016/S0022-5223(99)70346-6 Ewy, 1999, Inotropic infusions for chronic congestive heart failure. Medical miracles or misguided medicinals, J Am Coll Cardiol, 33, 572 Marius-Nunez, 1996, Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure, Am Heart J, 132, 805, 10.1016/S0002-8703(96)90315-4 Nony, 1994, Evaluation of the effect of phosphodiesterase inhibitors on mortality in chronic heart failure patients. A meta-analysis, Eur J Clin Pharmacol, 46, 191, 10.1007/BF00192547 Dies, 1986, Intermittent dobutamine in ambulatory outpatients with chronic heart failure (abstract), Circulation, 74, II38 Goldstein, 1998, Medical progress — implantable left ventricular assist devices, New Engl J Med, 339, 1522, 10.1056/NEJM199811193392107 Thoratec Laboratories. Recent small patient experience (BSA, 1.5 m2). September 1, 1998. Sidiropoulos, 1998, Pediatric circulatory support, J Heart Lung Transplant, 17, 1172 del Nido, 1994, Extracorporeal membrane oxygenation support as a bridge to pediatric cardiac transplantation, Circulation, 90, 66 Duncan, 1999, Mechanical circulatory support in children with cardiac disease, J Thorac Cardiovasc Surg, 117, 529, 10.1016/S0022-5223(99)70333-8 Anker, 1999, Cardiac cachexia — a syndrome with impaired survival and immune and neuroendocrine activation, Chest, 115, 836, 10.1378/chest.115.3.836 Falk, 1992, Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study, Am Heart J, 123, 136, 10.1016/0002-8703(92)90757-M Hsu, 1991, Acute pulmonary embolism in pediatric patients awaiting heart transplantation, J Am Coll Cardiol, 17, 1621, 10.1016/0735-1097(91)90657-U Maskin, 1984, High incidence of nonsustained ventricular tachycardia in severe congestive heart failure, Am Heart J, 107, 896, 10.1016/0002-8703(84)90824-X Doval, 1996, The GEISICA-GEMA investigators. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death, Circulation, 94, 3198, 10.1161/01.CIR.94.12.3198 Singh, 1995, Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia, New Engl J Med, 333, 77, 10.1056/NEJM199507133330201 Massie, 1996, The CHF STAT investigators. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure, Circulation, 93, 2128, 10.1161/01.CIR.93.12.2128 Kron, 1990, The automatic implantable cardioverter-defibrillator in young patients, J Am Coll Cardiol, 16, 896, 10.1016/S0735-1097(10)80338-9 Mitchell, 1998, Infant heart transplantation: improved intermediate results, J Thorac Cardiovasc Surg, 116, 242, 10.1016/S0022-5223(98)70123-0 Jobes, 1992, Carbon dioxide prevents pulmonary overcirculation in hypoplastic left heart syndrome, Ann Thorac Surg, 54, 150, 10.1016/0003-4975(92)91166-7 Tweddell, 1999, Phenoxybenzamine improves systemic oxygen delivery after the Norwood procedure, Ann Thorac Surg, 67, 161, 10.1016/S0003-4975(98)01266-1 Canter, 1993, Restrictive atrial septal communication as a determinant of outcome of cardiac transplantation for hypoplastic left heart syndrome, Circulation, 88, 456 Razzouk, 1996, Transplantation as a primary treatment for hypoplastic left heart syndrome: intermediate-term results, Ann Thorac Surg, 62, 1, 10.1016/0003-4975(96)00295-0 Morrow, 1997, The Pediatric Heart Transplantation Study Group. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation, J Heart Lung Transplant, 16, 1255 Chiavarelli, 1993, Cardiac transplantation for infants with hypoplastic left-heart syndrome, J Am Med Assoc, 270, 2944, 10.1001/jama.1993.03510240056032